Quantcast
Janssen, Novavax plan Mexican late stage COVID-19 vaccine trials, minister says - Metro US

Janssen, Novavax plan Mexican late stage COVID-19 vaccine trials, minister says

Phase 3 Johnson & Johnson's Janssen (COVID-19) vaccine trial location announced in California

MEXICO CITY (Reuters) – Johnson & Johnson’s Janssen unit has received the green light to carry out late stage trials for its coronavirus vaccine in Mexico, Foreign Minister Marcelo Ebrard on Tuesday. He said U.S. vaccine developer Novavax Inc earlier this month also presented health authorities with a request to conduct phase 3 testing in Mexico.

(Reporting by Ana Isabel Martinez and Drazen Jorgic; Editing by Frank Jack Daniel)

More from our Sister Sites